Tag: pharmaceuticals
-
Trial Shows Personalized Alzheimer’s Treatment Effects
A pilot test offers evidence of a personalized treatment combining changes in diet, exercise, brain stimulation, and medications can reverse cognitive decline.
-
Glucose Drug Reduces Heart Disease in People with Diabetes
14 June 2016. A drug to reduce glucose levels was shown in a clinical trial to reduce serious heart disease in people with type 2 diabetes also at high risk of heart disease. Results of the late-stage trial testing the drug liraglutide, marketed by drug-maker Novo Nordisk under the brand name Victoza, appear in yesterday’s…
-
Trial Underway Testing Drug to Reduce Chronic Cough
14 June 2016. A clinical trial testing a drug treating chronic cough — coughs continuing for 8 weeks or more — will begin recruiting participants in the U.K. to join other sites in the U.S. The U.K. sites are under the direction of National Institute for Health Research, testing a small molecule, or low molecular…
-
Consortium Aims to Upgrade Cell Manufacturing
13 June 2016. A collaboration between businesses and universities outlined a strategy to develop processes and technologies for large-scale manufacturing of human cells for therapies and diagnostics. The National Cell Manufacturing Consortium, residing at Georgia Institute of Technology, announced its technology road map for advance cell manufacturing today at a White House conference on organ…
-
FDA Approves Cholera Vaccine
13 June 2016. Food and Drug Administration approved for marketing the U.S. a vaccine to prevent cholera for travelers to regions in the world where contaminated food or water is causing the disease. Vaxchora by PaxVax Inc. in Redwood City, California is the first vaccine approved by the agency to prevent cholera. According to World…
-
New Diabetic Eye Disease Drugs Shown Not Cost-Effective
10 June 2016. An evaluation of two new biologic drugs to treat diabetic macular edema, an eye disease caused by diabetes, show the drugs do not provide enough additional benefit over much less expensive treatments to justify their higher price tags. The team led by Adam Glassman of the Jaeb Center for Health Research in…
-
Antibody Treatment Shown to Prevent Migraine
9 June 2016. A clinical trial shows an engineered antibody in one week reduced the number of headaches in people who experienced migraines for an average of 18 years. Results of the study testing the experimental treatment appear in yesterday’s issue of the journal Neurology, published by American Academy of Neurology. Migraine is a neurological syndrome…
-
Precision Medicine Shown to Boost Cancer Outcomes
7 June 2016. An analysis of results from early-stage clinical trials shows trials using treatments for cancer aimed at specific molecular targets had higher response rates and longer survival times than studies not using these targets. The team from University of California in San Diego, led by postdoctoral researcher Maria Schwaederlé, published its findings in…
-
Blood Test Guides Depression Drug Decisions
7 June 2016. A blood test for two key biomarkers can identify drugs for depression that match an individual’s condition with the disease, thus improving chances of success. A team from the lab of psychological medicine professor Carmine Pariante at Kings College London published its findings yesterday in the International Journal of Neuropsychopharmacology. Pariante’s team,…
-
Engineered T-Cells Get Leukemia Response
(6 June 2016) An early-stage clinical trial testing genetically engineered T-cells from the immune system, shows the treatments are effective against a form of leukemia when combined with chemotherapy drugs. Results of the trial were reported by study leader Jae Hong Park of Memorial Sloan Kettering Cancer Center on 4 June at a meeting of…